FBXW7 and transverse myelitis: AGO-Abs indicate a more severe clinical manifestation onset with a distinct phenotype of exclusively extensive transverse myelitis and prominent neurological impairment sequelae in NMOSD, sensory neuronopathies, several limbic encephalitis, and cerebellar syndrome (8, 11, 12).